is a novel renin inhibitor produced by Streptomyces sp. NR0516. It was isolated from fermentation broth by extraction with butyl alcohol, QAE-Toyopearl column chromatography and preparative HPLC.Cyclothiazomycin, which was determined to be a unique polythiazole-containing bicyclic peptide, exhibited inhibitory activity against human plasma renin with IC50 being 1.7/xm.
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The renin angiotensin system is implicated in several forms of hypertension. As a highly specific aspartic protease, renin cleaves angiotensinogen to form angiotensin I. This metabolic intermediate is further cleaved by angiotensin converting enzyme (ACE) to yield angiotensin II, which causes vasoconstriction and stimulates secretion of aldosterone and catecholamine leading to elevation of blood pressure. In this cascade reaction, renin is a rate-limiting enzyme1 '2) . Therefore, renin inhibitors are expected to the most effective in preventing these disorders. In recent years, many renin inhibitors have been designed by the peptide mimetic approach3~5). In order to obtain further detailed information for the medicinal chemistry of the renin inhibitors, however, it is worth while to seek newtypes of inhibitors from microorganisms. In the course of a renin inhibitor screening program, cyclothiazomycin ( Fig. 1) was isolated from the fermentation broth of Streptomyces sp. NR0516. The structure of cyclothiazomycin was determined to be a unique polythiazole-containing bicyclic peptide by spectral analysis6'7). In this paper, taxonomy, fermentation, isolation and physico-chemical properties of cyclothiazomycin are reported.
Taxonomyof the Producing Strain
The producing organism, strain NR0516was isolated from a soil sample collected at Kamakura, Kanagawa,Japan. The spore chains were of the spirals type and each had more than 30 spores per chain. The spores were oval (0.8~1.1 x 1.0~1.2jan) and their surface was smooth. Sclerotic granules, sporangia or flagellated spores were not observed. The cultural and physiological characteristics and the utilization of carbohydrate, which were observed after incubation at 27°C for 2 weeks, are shown in Tables 1, 2 and 3, respectively. The substrate mycelia grew well on all the media tested and were either colorless, yellow or yellowish olive. The aerial mycelia were formed abundantly on yeast extract -malt extract agar, oatmeal The color names used in this table were based on the Color Standerd (Nihon Shikisai Co., Ltd.). agar and inorganic salts -starch agar, and showed grayish color after sporulation. A soluble pigment was yellow on most media. Whole cell hydrolysates of strain NR0516 contained L,L-diaminopimelic acid. Glycine was detected in the cell wall. The strain was thereby placed in the type I cell wall group of Lechevalier et al.8\ Based on the taxonomic properties described above, the producing strain NR0516 was assigned to the genus Streptomyces. The definite nomenclature of the producing organism will be reported elsewhere.
Fermentation
The frozen mycelial suspension of Streptomyces sp. NR0516 (15ml) was inoculated into a 500-ml baffled Erlenmeyer flask containing 100ml of a medium consisting of glucose 1.5%, soluble starch 1.0%, Polypeptone 0.5%, meat extract 0.75%, yeast extract 0.1%, K2HPO40.05%, MgSO4-7H2O 0.05%, CaCO30.2% and Nissan Disfoam CA-115 0.05%. The medium was adjusted to pH 7.0 before addition of CaCO3. The inoculated flask was incubated on a rotary shaker at 27°C for 3 days at 190rpm to make a seed culture. The resultant seed culture (12ml) was transferred into a 3-liter baffled Erlenmeyer flask containing 600ml of the same medium as above followed by incubation on a rotary shaker at 27°C for 3 days at 100 rpm. This seed culture (600 ml) was transferred into a 50-liter jar fermenter containing 30 liters of the same mediumas described above except that 0.3% of Nissan Disfoam CA-115 was added to the medium. The fermentation was carried out at 27°C with aeration of 30 liters per minute and agitation at 350rpm for 69 hours (Fig. 2) .
Isolation
Cyclothiazomycin was isolated from the broth filtrate as outlined in Fig. 3 and the activity was monitored by testing renin inhibitory activity. Humanplasma renin activity was measured by radio-immuno assay (MEDIPRO)for angiotensin I which was generated during incubation of plasma at 37°C for 3 hours. The broth filtrate (3.2 liters) was adjusted to pH 7.0 with aqueous NaOHand extracted with butyl alcohol. The organic layer was concentrated under reduced pressure. The residue was dissolved in 100 ml of H2Oand then applied to a QAE-Toyopearl (coarse grade) column and eluted stepwisely with aqueous NaCl solutions (0, 0.3, 0.4 and 0.5 m). The active fractions collected were then adjusted to pH 7.0 with aqueous NaOHand extracted with butyl alcohol. The organic layer was evaporated under reduced pressure to give crude cyclothiazomycin (351mg). This crude powder was purified by HPLC using a Toso HLC-837 system with a YMC-pack C8 (30mmx250mm) and eluted with a mixture of methanol and 0.05m aqueous NaH2PO4solution (7: 3) at a flow rate of 43ml/minute. Cyclothiazomycin detected by UVabsorption at 210nm produced a peak with a retention time of 8.5 minutes. The eluate containing cyclothiazomycin was concentrated to a small volume and then extracted with butyl alcohol at pH 7.0 for desalting. The organic layer was evaporated under reduced pressure and the residue was triturated with ethyl acetate to give a light brown powder (215 mg) of pure cyclothiazomycin. Table 4 . Cyclothiazomycin obtained as a sodium salt is soluble in water, chloroform -methanol mixture and mixed aqueous-organic solvents such as MeOH-H2O, dimethyl sulfoxide (DMSO)-H2O and acetone -H2O. It is slightly soluble in methanol, DMSOand iV,iV-dimethylformamide. Cyclothiazomycin is detected on TLC plates using short-wavelength UVlight and ninhydrin reagent for visualization. Its UVspectrum (Fig. 4) is similar to that of the peptide antibiotics containing a polythiazole residue including saramycetin9'10), cystamycin11*, jingsimycin12) and 5102-213), the structures of which are still unknown. The IR spectrum (Fig. 5) shows absorbance at 3350 and 1670cm"1 consistent with a peptide structure. The molecular formula (C59H64N18O14S7) was determined based on HRFABmass using a dual target probe (Obsd Nochange of UVspectrum was observed in acidic and basic solution. Biological Characteristics Cyclothiazomycin exhibited inhibitory activity against humanplasma renin with an IC50 of 1.7 fiM. This activity was much greater than that against rat plasma renin (IC50 81 fiM) and dog plasma renin (IC50 177jUM). Cyclothiazomycin showed selective activity against renin; no inhibitory activity was obtained up to 212yMagainst porcine pepsin, another aspartic protease, and several other enzymes JUNE 1991 belonging to serine-, thiol-or metallo-proteases. Cyclothiazomycin also showed weak anti-fungal activity. The detailed biological study will be reported in due course.
Discussion
Cyclothiazomycin was isolated from the cultured broth of Streptomyces sp. NR0516by solvent extraction, QAE-columnchromatography and preparative HPLC.Since cyclothiazomycin exhibited inhibitory activity against human plasma renin, it may be interesting to investigate the renin inhibitory activity of other polythiazole-containing peptides. Since cyclothiazomycin showed no blood pressure decrease in sodium-depleted squirrel monkeys after po (3 mg/kg) and iv (1 mg/kg) administration (data not shown), it is not suitable for therapeutic use. Webelieve, however, that clarification of the active site of cyclothiazomycin will provide structure-activity information for medicinal chemistry to prepare useful analogues and that screening of renin inhibitors from nature will provide non-peptide lead compounds for this therapeutic area.
